Clinical trial
Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart…
NCT00338455 · Scios, Inc., Industry · Terminated
Key facts
| NCT number | NCT00338455 |
|---|---|
| Title | Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC |
| Official title | Investigation of the Use of Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC |
| Lead sponsor | Scios, Inc., Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Congestive Heart Failure, Cardiac Transplantation, Renal Insufficiency, Renal Failure |
| Intervention type | Drug |
| Interventions | Natrecor (nesiritide)+Standard Care+dobutamine or milrinone, Placebo+Standard Care+dobutamine or milrinone |
| Enrollment | 16 |
| Start date | Sep 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Jun 20, 2006 |
| Last update posted | Dec 8, 2014 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: